Amaravati was conceived as Andhra Pradesh’s greenfield capital after the state’s bifurcation in 2014. The city became one of India’s most debated infrastructure projects, with changing political ...
More than 70% of massive stars are born in close binary systems, where gravitational tugs and mass transfer between companions dramatically alter their evolution. Yet once the interaction ends—whether ...
We have updated our Privacy Policy. Please review to learn more. By continuing to use our services, you agree to these updates. By Nicholas Slayton Published Jul 31 ...
Please provide your email address to receive an email when new articles are posted on . GLP-1s can have a positive impact on bones and joints by reducing bone resorption and joint inflammation.
Dallas VA hospital to study the impact of GLP-1s on alcohol use disorder, as part of broader study. Republican senator’s Trump questions at secret meeting exposed Son flees US as bodies found at ...
Good Monday morning in New York City, where drivers in the Bronx have figured out how to get away with double-parking in bus lanes. Gothamist is funded by sponsors and member donations Gothamist is ...
Happy Thursday morning in New York City, where there can be a fuzzy line between stooping and stealing. Gothamist is funded by sponsors and member donations Gothamist is funded by sponsors and member ...
Prescribing doctors often warn of the medications’ potential side-effects – but unexpected impacts on romantic relationships are less understood For Jennifer, obesity was the obvious culprit for most ...
Researchers have helped unravel the mystery of why certain pairs of stars pulse with regular, long-period bursts of radio waves. The particular class of objects observed comes in pairs that always ...
GLP-1s have become a household name for their role in weight loss. Now, researchers are studying whether they could help veterans living with alcohol use disorder. The Minneapolis VA Health Care ...
There are more than 400,000 national veterans diagnosed with alcohol use disorder (AUD). A new federal clinical trial is examining whether mainstream GLP-1s can help reverse the trend. The U.S.